Proto Labs (PRLB) Gains from Sales and Divestitures (2014 - 2022)

Proto Labs has disclosed Gains from Sales and Divestitures across 9 years of filings, most recently posting $130452.0 for Q4 2022.

• Gains from Sales and Divestitures for Q4 2022 came in at $130452.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2022 was $130452.0 (changed N/A YoY), and the FY2022 annual result was $130452.0, changed N/A from the prior year.
• Gains from Sales and Divestitures came in at $130452.0 for Q4 2022 at Proto Labs, up from $119315.0 in the prior quarter.
• In the past five years, Gains from Sales and Divestitures ranged from a high of $130452.0 in Q4 2022 to a low of $7113.0 in Q1 2020.
• The 5-year median for Gains from Sales and Divestitures is $83456.0 (2018), against an average of $69696.9.
• Across the five-year window, Gains from Sales and Divestitures slumped 92.58% in 2020 and jumped 322.3% in 2021, its largest moves.
• Proto Labs' Gains from Sales and Divestitures stood at $83456.0 in 2018, then grew by 10.95% to $92597.0 in 2019, then rose by 10.09% to $101941.0 in 2020, then increased by 11.16% to $113315.0 in 2021, then advanced by 15.12% to $130452.0 in 2022.
• The last three Gains from Sales and Divestitures figures came in at $130452.0 (Q4 2022), $119315.0 (Q2 2022), and $35207.0 (Q1 2022), per Business Quant data.